Oct 14, 2020, 01:50 AM by Michael Croft

Bio-IT World  | On its 10th anniversary, the annual Trends from the Trenches presentation from Chris Dagdigian, co-founder and principle consultant of BioTeam, and friends had lost none of its characteristic candor and punch—even in a virtual environment and even as Dagdigian successfully continued to limit his own speaking time.

Oct 12, 2020, 14:37 PM by Abhinav Singh

PRINCETON, NJ - Oct 12, 2020 - WCG announced today the unification of its five industry-leading IRBs – Western IRB (WIRB), Copernicus Group IRB (CGIRB), Midlands IRB (MLIRB), New England IRB (NEIRB), and Aspire IRB – into the single WCG IRB brand

Oct 12, 2020, 09:15 AM by Abhinav Singh

CAMBRIDGE, UNITED KINGDOM - Dec 10, 2020 - Cambridge, UK, 9th October 2020: Mogrify Limited (Mogrify®), a UK company aiming to transform the development of ex vivo cell therapies and pioneer the field of in vivo reprogramming therapies, today announced the introduction of EpiMOGRIFY

Oct 12, 2020, 08:14 AM by Abhinav Singh

WESTBURY, NY - Oct 12, 2020 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced the publication of research describing the use of HEPATOPAC® cultures with a targeted in vitro assay to identify small molecule drugs with high potential for drug-induced liver injury (DILI)

Oct 12, 2020, 02:15 AM by Michael Croft

Bio-IT World | The Bio-IT World Conference & Expo Virtual launched last week with an opening plenary keynote from Drs. Susan Gregurick, Associate Director for Data Science at NIH and Rebecca Baker, Director of the HEAL Initiative at NIH.

Oct 10, 2020, 01:53 AM by Abhinav Singh

NY, NY - Oct 10, 2020 - On October 8, 2020, Alfa Chemistry Materials announces to provide wide options of resins for customers worldwide, which have broad applications in decoration, manufacture of plastics as well as other fields

Oct 9, 2020, 04:50 AM by Michael Croft

Bio-IT World | MIT’s preprint reviewers debunk synthetic SARS-CoV-2 paper, genetic analysis of virus samples show most COVID-19 cases in Southern California early in the pandemic are linked to New York state via Europe, not directly from China, vaccines should not be affected by the dominant ‘G-strain’, severe cases of COVID-19 develop a novel T cell subset that can potentially kill B cells, and MS drug inhibits virus growth. Plus, NIH funds COVID-10 vaccine using bovine adenovirus.

Oct 8, 2020, 15:15 PM by Abhinav Singh

SAN DIEGO, CA, UNITED KINGDOM - Oct 8, 2020 - Leading contract provider of integrated discovery, development and manufacturing services for biologics and bioconjugates, Abzena, has invested $60m into a new facility for late phase and commercial cGMP manufacturing

Oct 7, 2020, 19:00 PM by Michael Croft

Bio-IT World  Day two of the Bio-IT World Conference & Expo Virtual was highlighted by a plenary keynote on artificial intelligence (AI) and citizen science, a new data commons maturity model, guidance for FAIRifying data, augmented intelligence systems for biological data, and much more. 

Oct 7, 2020, 05:07 AM by Michael Croft

BOURNEMOUTH, UNITED KINGDOM - Oct 7, 2020 - Solentim is pleased to announce the adoption of its VIPS™ single cell seeding platform and Cell Metric® CLD into Samsung Biologics’ new research and development facility in San Francisco, CA

Oct 7, 2020, 02:10 AM by Michael Croft

CAMBRIDGE, UNITED KINGDOM - Oct 6, 2020 - A partnership between Sandia National Laboratories and the Boston firm BioBright LLC to improve the security of synthetic biology equipment has become more relevant after the United States and others issued warnings that hackers were using the COVID-19 pandemic to increase their activities

Oct 6, 2020, 19:15 PM by Michael Croft

Bio-IT World  The Bio-IT World Conference & Expo Virtual launched today with an open plenary keynote from Drs. Susan Gregurick, Associate Director for Data Science at NIH and Rebecca Baker, Director of the HEAL Initiative at NIH. The rest of the day was full of workshops covering AI in clinical trials and drug discovery, tools for moving data quickly and safely, wearables to gather data, and much more.

Oct 6, 2020, 17:15 PM by Michael Croft

CAMBRIDGE, UK - Oct 6, 2020 - PetaGene and NVIDIA announce seamless integration of PetaGene's PetaSuite tools as a standard part of NVIDIA Clara Parabricks Pipelinesx

Oct 6, 2020, 13:08 PM by Michael Croft

JERSEY CITY, NJ, US - Oct 6, 2020 - TrialScope, the global leader in clinical trial disclosure and transparency management technology, has added a new study sponsor to its growing customer roster

Oct 6, 2020, 09:57 AM by Michael Croft

MOSCOW, RUSSIA - Oct 6, 2020 - InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, releases the new version of mathematical simulation workbench DBSolveOptimum 2020

Oct 6, 2020, 04:53 AM by Michael Croft

- Sep 27, 2020 - Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has officially opened its new multi-million-pound Material Science Centre (MSC), after announcing the investment last year

Oct 5, 2020, 19:05 PM by Michael Croft

Bio-IT World  10x Genomics today announced its second in situ sequencing acquisition: Boston-based ReadCoor, Inc. for cash and stock consideration of $350 million. In late August, 10x Genomics’ acquired Stockholm-based Cartana, developers of in situ RNA analysis technology.

Oct 5, 2020, 13:32 PM by Michael Croft

CAMBRIDGE, UNITED KINGDOM - Oct 5, 2020 - Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic and into GMP manufacturing has announced the appointment of Giovanni Escobar as Senior Vice President (SVP) and Site Head of its Bristol Operations

Oct 5, 2020, 10:01 AM by Michael Croft

PROVIDENCE, RI, UNITED STATES - Oct 5, 2020 - VERICHEM LABORATORIES is pleased to announce the availability of a ready-to-use, liquid stable Electrolyte Standard Kit

Oct 2, 2020, 10:40 AM by Michael Croft

Bio-IT World | Genetic variations not driving outcomes, bio-sensing viral translation, pursuit of a passive vaccine, an Android app that analyzes the SARS-CoV-2 genome, potential antibody cocktails, targeting the hairpin, spike protein may be superantigen, implicating MAIT cells, three mutations common to COVID cases in the U.S., naturally occurring lipid and enzyme hold promise, research using breathing human lungs cells, widespread preexisting immunity, and a Neandertal gene variant that triples the risk of severe disease. Plus, an interactive exhibition about COVID-19 and an international team of experts will study how viral diseases "spill over" from animals to humans.